Rachel Gonzaga has been appointed Associate Director at OVID

A former global communications director, GSK, Rachel Gonzaga, has been appointed Associate Director at OVID, where she will focus on leading the pharmaceutical PR and corporate communications officer. Previously, Rachel led global communications at GSK for the inhaled respiratory medicines team.

Having previously worked for Nature publishing group and been a Science Press Manager for Cancer Research UK, Gonzaga’s background is in science communications and oncology.

Managing Director and Founder at OVID Health, Jenny Ousbey, stated: “Rachel is fantastically knowledgeable and commands respect in the industry as a strategic pharma PR pro. I’m thrilled to welcome her as we continue to reinvent healthcare communications for our clients in life science and healthcare comms.”

Gonzaga stated: “OVID has been on my radar for a while as an agency going places with a serious commitment to patient-centric communications. I’m delighted to be joining their award-winning team. I look forward to supporting their ambitious plans for growth and leading on a number of exciting client programmes in a range of therapy areas.”